Efficacy Study of CYT997 in Combination With Carboplatin in Glioblastoma
Status:
Terminated
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
This study seeks to (i) determine the safe dose of CYT997 when given in combination with
carboplatin in patients with relapsed glioblastoma multiforme (glioma) and (ii) to determine
whether the combination of CYT997 with carboplatin is a useful treatment for glioma.